Eli Lilly and Comp. (LLY) stock forecast for 2026. Forecast tables and graphs.

Eli Lilly and Comp. (LLY) stock forecast for 2026

The forecast has been updated: June 10, 2021 8:38


Eli Lilly and Comp. stock price online today

Analyst Target Price

215.41

Dividend Date

10.06.2021

Ex Dividend Date

13.05.2021

Last Split Factor

2:1

Last Split Date

16.10.1997

Should you buy or sell Eli Lilly and Comp. stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? Eli Lilly and Comp. stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $215.41 target price for Eli Lilly and Comp. stock stock.

Today 200 Day Moving Average is the support level (186.9924 $).

50 Day Moving Average is the support level (195.2606 $).




LLY Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 233.57 221.73 247.85 10.54 %
Feb 236.91 225.52 255.39 11.70 %
Mar 244.92 226.45 251.93 10.11 %
Apr 274.53 254.55 302.37 15.82 %
May 305.58 278.17 313.92 11.39 %
Jun 302.01 285.52 325.17 12.19 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Eli Lilly and Comp. stock.


Eli Lilly and Comp. overview

Eli Lilly and Comp. Address

Lilly Corporate Center, Indianapolis, IN, United States, 46285

Market Capitalization

216 279 334 912 $

EBITDA

8 494 000 128

PE Ratio

33.7605

PEG Ratio

2.144

Dividend Per Share

3.07

Dividend Yield

0.0139

EPS

6.68

Quarterly Earnings Growth YOY

-0.069

Quarterly Revenue Growth YOY

0.161

Trailing PE

33.7605

Forward PE

25.8398

EV To Revenue

8.1181

EV To EBITDA

23.5593

52 Week High

226.73

52 Week Low

127.4597

50 Day Moving Average

195.2606

200 Day Moving Average

186.9924

Shares Outstanding

959025024

Shares Float

857101913

Shares Short Prior Month

6376547

Short Ratio

2.84

Percent Insiders

0.153

Percent Institutions

83.77

Eli Lilly and Comp. stock forecast for this year


Eli Lilly and Comp. stock forecast for Jan 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 233.57. Negative monthly dynamics of the instrument is expected with 10.536% volatility is expected.

Pessimistic forecast: 221.73

Optimistic: 247.85


Eli Lilly and Comp. stock forecast for Feb 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 236.91. Positive monthly dynamics of the instrument is expected with 11.698% volatility is expected.

Pessimistic forecast: 225.52

Optimistic: 255.39


Eli Lilly and Comp. stock forecast for Mar 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 244.92. Positive monthly dynamics of the instrument is expected with 10.111% volatility is expected.

Pessimistic forecast: 226.45

Optimistic: 251.93


Eli Lilly and Comp. stock forecast for Apr 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 274.53. Positive monthly dynamics of the instrument is expected with 15.816% volatility is expected.

Pessimistic forecast: 254.55

Optimistic: 302.37


Eli Lilly and Comp. stock forecast for May 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 305.58. Positive monthly dynamics of the instrument is expected with 11.389% volatility is expected.

Pessimistic forecast: 278.17

Optimistic: 313.92


Eli Lilly and Comp. stock forecast for Jun 2026.
Estimated Average Forecasted Eli Lilly and Comp. Price: 302.01. Negative monthly dynamics of the instrument is expected with 12.195% volatility is expected.

Pessimistic forecast: 285.52

Optimistic: 325.17



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 110.48 (14.06.2021) 0.52 %
AbbVie Inc.
ABBV 115.4 (14.06.2021) -0.02 %
Aeterna Zentaris Inc.
AEZS 1.02 (14.06.2021) -2.86 %
Allakos Inc.
ALLK 90.87 (14.06.2021) -3.24 %
Allogene Therapeutics, Inc.
ALLO 25.37 (14.06.2021) -2.80 %
Amgen Inc.
AMGN 241.19 (14.06.2021) -0.65 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (14.06.2021) 1.81 %
Aurora Cannabis Inc.
ACB 9.67 (14.06.2021) -1.53 %
Becton Dickinson and Company
BDX 242.72 (14.06.2021) 0.03 %
Biogen Inc.
BIIB 406.14 (14.06.2021) 2.40 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 100.4 (14.06.2021) -4.40 %
BioNTech SE
BNTX 220.58 (14.06.2021) -7.53 %
bluebird bio, Inc.
BLUE 33.53 (14.06.2021) -1.67 %
Boston Scientific Corp.
BSX 42.54 (14.06.2021) -0.86 %
Bristol-Myers Squibb Company
BMY 67.29 (14.06.2021) -0.07 %
Canopy Growth Corp.
CGC 25.14 (14.06.2021) -2.82 %
Castle Biosciences, Inc.
CSTL 71.86 (14.06.2021) -0.04 %
Eli Lilly and Company
LLY 226.1 (14.06.2021) 0.90 %
Emergent BioSolutions Inc.
EBS 61.79 (14.06.2021) -2.71 %
Exelixis, Inc.
EXEL 22.76 (14.06.2021) -0.96 %
G1 Therapeutics, Inc.
GTHX 22.75 (14.06.2021) 5.23 %
Gilead Sciences, Inc.
GILD 68.15 (14.06.2021) -0.90 %
GlaxoSmithKline plc
GSK 40.49 (14.06.2021) 0.85 %
GoodRx Holdings, Inc.
GDRX 38.33 (14.06.2021) 4.21 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 82.64 (14.06.2021) 0.07 %
Inovio Pharmaceuticals, Inc.
INO 8.91 (14.06.2021) -2.09 %
Johnson & Johnson
JNJ 165.37 (14.06.2021) 0.25 %
Medtronic plc.
MDT 124.15 (14.06.2021) 0.30 %
Merck & Co., Inc.
MRK 75.45 (14.06.2021) -1.08 %
Moderna, Inc.
MRNA 207.41 (14.06.2021) -5.23 %
Novartis AG
NVS 93.59 (14.06.2021) 0.97 %
Novavax, Inc.
NVAX 207.71 (14.06.2021) -0.94 %
ObsEva SA
OBSV 3.17 (14.06.2021) -0.63 %
OrganiGram Holdings Inc.
OGI 3.14 (14.06.2021) -1.26 %
Pfizer Inc.
PFE 39.63 (14.06.2021) -1.30 %
Regeneron Pharmaceuticals, Inc.
REGN 528.75 (14.06.2021) 0.61 %
Sanofi
SNY 54.25 (14.06.2021) 0.84 %
Schrodinger, Inc.
SDGR 76.34 (14.06.2021) -1.51 %
Senseonics Holdings, Inc.
SENS 3.96 (14.06.2021) -1.25 %
Sorrento Therapeutics, Inc.
SRNE 9.46 (14.06.2021) 6.65 %
Stryker Corp.
SYK 255.69 (14.06.2021) -0.04 %
Sundial Growers Inc.
SNDL 1.06 (14.06.2021) 0.95 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 11.05 (14.06.2021) -0.54 %
Thermo Fisher Scientific Inc.
TMO 470.07 (14.06.2021) 1.06 %
Tilray, Inc.
TLRY 19.16 (14.06.2021) -3.67 %
UnitedHealth Group, Inc.
UNH 399.16 (14.06.2021) 0.32 %
Veeva Systems Inc.
VEEV 303.9 (14.06.2021) 1.57 %
Zomedica Corp.
ZOM 0.9458 (14.06.2021) -0.08 %
Zynerba Pharmaceuticals, Inc.
ZYNE 5.66 (14.06.2021) 0.35 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.